Biomarkers for early detection of non-alcoholic steatohepatitis: implications for drug development and clinical trials.
about
Antibody-Directed Glucocorticoid Targeting to CD163 in M2-type Macrophages Attenuates Fructose-Induced Liver Inflammatory Changes.A comparison of FibroMeter™ NAFLD Score, NAFLD fibrosis score, and transient elastography as noninvasive diagnostic tools for hepatic fibrosis in patients with biopsy-proven non-alcoholic fatty liver disease.
P2860
Biomarkers for early detection of non-alcoholic steatohepatitis: implications for drug development and clinical trials.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Biomarkers for early detection ...... velopment and clinical trials.
@en
type
label
Biomarkers for early detection ...... velopment and clinical trials.
@en
prefLabel
Biomarkers for early detection ...... velopment and clinical trials.
@en
P1433
P1476
Biomarkers for early detection ...... evelopment and clinical trials
@en
P2093
Yusuf Yilmaz
P304
P356
10.2174/13894501113146660215
P50
P577
2013-10-01T00:00:00Z